Liver transplantation for hepatitis C virus related cirrhosis

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 14, Issue 2, 2000, Pages 307-325

  Crosbie, Orla M ^a   Alexander, Graeme J M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Hepatocellular carcinoma; Immunosuppression; Interferon; Progressive cholestatic hepatitis; Recurrent hepatitis; Retransplantation; Viraemia

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; RIBAVIRIN;

GRAFT FAILURE; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; RECURRENCE RISK; REVIEW; TIME;

EID: 0034045720     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.1999.0078     Document Type: Article

References (90)

1. Wright T, Berenguer M. Hepatitis C and liver transplantation. Gut. 45:1999;159-163.
2. Prieto M, Berenguer M, Rayon J M. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following liver transplantation: relationship with rejection episodes. Hepatology. 29:1999;250-256.
3. UKTSSA.
4. Niederau C, Lange S, Heintges T. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology. 28:1998;1687-1695.
5. Serfaty L, Aumaitre H, Chazouilleres O. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology. 27:1998;1435-1440.
6. Hu K-Q, Tong M J. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology. 29:1999;1311-1316.
7. Fattovich G, Giustina G, Degos F. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology. 112:1997;463-472.
8. Lucey M R, Brown K A, Everson G T. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transplantation and Surgery. 3:1997;628-637.
9. Hepatology. 20:1994;63S-68S.
10. Gane E J, Portmann B C, Naoumov N V. Long-term outcome of hepatitis C infection after liver transplantation. New England Journal of Medicine. 334:1996;815-820.
11. Charlton M, Seaberg E, Wiesner R. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology. 28:1998;823-830.
12. Ascher N L, Lake J R, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology. 20:1994;24S-27S.
13. Feray C, Gigou M, Samuel D. The course of hepatitis C virus infection after liver transplantation. Hepatology. 20:1994;1137-1143.
14. Boker K HW, Dalley G, Bahr M J. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology. 25:1997;203-210.
15. Wright T L, Donegan E, Hsu H H. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 103:1992;317-322.
16. Shah G, Demetris A J, Gavaler J S. Incidence, prevalence and clinical course of hepatitis C following liver transplantation. Gastroenterology. 103:1992;323-329.
17. Schiffman M L. Management of posttransplantation viral hepatitis C. Liver Transplantation and Surgery. 4:1998;S79-S86.
18. Gane E J, Maertens G, Ducatteeuw A. Antibodies to hepatitis C virus envelope proteins correlate with hepatitis C viraemia after liver transplantation. Transplantation. 67:1996;78-84.
19. Tabatabai L, Lewis W D, Gordon F. Fibrosis/cirrhosis after orthotopic liver transplantation. Human Pathology. 30:1999;39-47.
20. Caronia S, Coleman N, Wight D GD. Accelerated progression of fibrosis in liver grafts infected with hepatitis C. Hepatology. 26:1997;155A.
21. Ferrell L D, Wright T L, Roberts J. Hepatitis C viral infection in liver transplant recipients. Hepatology. 16:1992;865-876.
22. Bodenheimer H C. Hepatitis B and C: an overview. Liver Transplantation and Surgery. 4:1998;S65-S67.
23. Ye M Q, Thung S N. Hepatitis after transplantation. Liver Transplantation and Surgery. 4:1998;S68-S72.
24. Petrovic L M, Villamil F G, Vierling J M. Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation. Liver Transplantation and Surgery. 3:1997;398-406.
25. Schluger L K, Sheiner P A, Thung S N. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology. 23:1996;971-976.
26. Di Martino V, Saurini F, Samuel D. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation. Hepatology. 26:1997;1343-1350.
27. Gane E J, Naoumov N V, Qian K-P. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology. 110:1996;167-177.
28. Asanza C G, Garcia-Monzon C, Clemente G. Immunohistochemical evidence of immunopathogenetic mechanisms in chronic hepatitis C recurrence after liver transplantation. Hepatology. 26:1997;755-763.
29. Vargas H E, Laskus T, Wang L F. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology. 117:1999;149-153.
30. Rosen H R, Shackleton C R, Higa L. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. American Journal of Gastroenterology. 92:1997;1453-1457.
31. Papatheodoridis G V, Barton S GRG, Andrew D. Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppression regimes. Gut. 45:1999;427-434.
32. Sullivan D G, Wilson J J, Carithers R L. Multigene tracking of hepatitis C virus quasispecies after liver transplantation: correlation of genetic diversity in the envelope region with asymptomatic or mild disease patterns. Journal of Virology. 72:1998;10036-10043.
33. Feray C, Caccamo L, Alexander G JM. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. Gastroenterology. 117:1999;619-625.
34. Feray C, Gigou M, Samuel D. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology. 108:1995;1088-1096.
35. Costes V, Durand L, Pageaux G P. Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. American Journal of Pathology. 111:1999;252-258.
36. Vargas H E, Laskas T, Wang L F. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transplantation and Surgery. 4:1998;22-27.
37. Gayowski T, Singh N, Marino I R. Hepatitis C virus genotypes in liver transplant recipients. Transplantation. 64:1997;422-426.
38. Zhou S, Terrault N A, Ferrell L. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viraemia. Hepatology. 24:1996;1041-1046.
39. Tisone G, Baiocchi L, Orlando G. Hepatitis C reinfection after liver transplantation in relation to virus genotype. Transplantation Proceedings. 31:1999;490-491.
40. Belli L S, Zavaglia C, Alberti B. Immunogenetic factors, HCV genotypes and HCV recurrence after liver transplantation. Transplantation Proceedings. 31:1998;483-484.
41. Rosen H R, Gretch D R, Oehlke M. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. Transplantation. 65:1998;1178-1182.
42. Baiocchi L, Tisone G, Palmieri G. Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation. Liver Transplantation and Surgery. 4:1998;441-447.
43. Rosen H R, Chou S, Corless C L. Cytomegalovirus viraemia; risk factor for allograft cirrhosis after liver transplantation for hepatitis C. Transplantation. 64:1997;721-726.
44. Berenguer M, Terrault N A, Piatak M. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology. 111:1996;1569-1575.
45. Casavilla E A, Rakela J, Kapur S. Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. Liver Transplantation and Surgery. 4:1998;448-454.
46. Okuda K, Ohtsuki T, Obata H. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer. 56:1985;918-928.
47. Hepatology. 28:1998;751-755.
48. Bruix J, Llovet J M, Castells A. Transarterial embolisation versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomised, controlled trial in a single institution. Hepatology. 27:1998;1578-1583.
49. McPeake J R, O'Grady J G, Zaman S. Liver transplantation for primary hepatocellular carcinoma: tumour size and number determine outcome. Journal of Hepatology. 18:1993;226-234.
50. Llovet J M, Bruix J, Fuster J. Liver transplantation for small hepatocellular carcinoma: the tumour-node-metastasis classification does not have prognostic power. Hepatology. 27:1998;1572-1577.
51. Min A D, Saxena R, Thung S N. Outcome of hepatitis C patients with and without hepatocellular carcinoma undergoing liver transplantation. American Journal of Gastroenterology. 93:1998;2148-2153.
52. Saxena R, Ye M Q, Emre S. De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis. Liver Transplantation and Surgery. 5:1999;81-82.
53. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology. 27:1998;273-276.
54. Testa G, Goldstein R M, Netto G. Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. Transplantation. 65:1998;925-929.
55. Magrin S, Craxi A, Fabiano C. Hepatitis C viraemia in chronic liver disease; relationship to interferon-α or corticosteroid treatment. Hepatology. 19:1994;273-279.
56. Berenguer M, Prieto M, Cordoba J. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. Journal of Hepatology. 28:1998;756-763.
57. Sheiner P, Schwartz M E, Mor E. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology. 21:1995;30-34.
58. Wiesner R H. A long-term comparison of tacrolimus (FK506) versus cyclosporin in liver transplantation. Transplantation. 66:1998;493-499.
59. Platz K P, Muelleer A R, Willimski C. Indication for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation. Transplantation Proceedings. 30:1998;2232-2233.
60. Rosen H R, Martin P. Hepatitis C infection in patients undergoing liver retransplantation. Transplantation. 66:1998;1612-1616.
61. Sheiner P A, Schluger L K, Emre S. Retransplantation for recurrent hepatitis C. Liver Transplantation and Surgery. 3:1997;130-136.
62. Rosen H R, O'Reilly P M, Shackleton C R. Graft loss following liver transplantation in patients with chronic hepatitis C. Transplantation. 62:1996;1773-1776.
63. Rosen H R, Madden J P, Martin P. A model to predict survival following liver retransplantation. Hepatology. 29:1999;365-370.
64. Casavilla F A, Lee R, Lim J. Outcome of liver retransplantation for recurrent hepatitis C infection. Hepatology. 22:1995;153A.
65. Singh N, Gayowski T, Wannstedt C F. Interferon-α for prophylaxis of recurrent viral hepatitis C in liver transplant patients. Transplantation. 65:1998;82-86.
66. Sheiner P A, Boros P, Klion F M. The efficacy of prophylactic interferon alpha-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology. 28:1998;831-838.
67. Wright H I, Gavaler J S, Van Thiel D H. Preliminary experience with α2b-interferon therapy of viral hepatitis in liver allograft recipients. Transplantation. 53:1992;121-123.
68. Wright T L, Combs C, Kim M. Interferon-α therapy for hepatitis C virus infection after liver transplantation. Hepatology. 20:1994;773-779.
69. Jain A, Demetris A J, Manez R. Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon. Liver Transplantation and Surgery. 4:1998;197-203.
70. Vargas V, Charco R, Castells L. Alpha-interferon for acute hepatitis C in liver transplant patients. Transplantation Proceedings. 27:1995;1222-1223.
71. Feray C, Samuel D, Gigou M. An open trial of interferon alpha recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology. 22:1995;1084-1089.
72. Dousset B, Conti F, Houssin D. Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients. New England Journal of Medicine. 330:1994;1160-1161.
73. Davis G L, Esteban-Mur R, Rustgi V. Interferon α-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. New England Journal of Medicine. 339:1998;1493-1499.
74. McHutchinson J G, Gordon S C, Schiff E R. Interferon α-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. New England Journal of Medicine. 339:1998;1485-1492.
75. Cattral M S, Krajden M, Wanless I R. A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation. 61:1996;1483-1488.
76. Gane E J, Lo S K, Riordan S M. A randomised study comparing ribavirin and interferon alpha monotherapy for hepatitis C recurrence after liver transplantation. Hepatology. 27:1998;1403-1407.
77. Mazzaferro V, Regalia E, Pulvirenti A. Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination. Transplantation Proceedings. 29:1997;519-521.
78. Fischer L, Sterneck M, Valentin-Gamazo C. Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha. Transplantation Proceedings. 31:1999;494-495.
79. Bizollon T, Palazzo U, Ducerf C. Pilot study of the combination of interferon alpha and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology. 26:1997;500-504.
80. Seeff L B, Zimmerman H J, Wright E C. A randomised, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. Gastroenterology. 72:1977;111-121.
81. Feray C, Gigou M, Samuel D. Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Annals of Internal Medicine. 128:1998;810-816.
82. Farci P, Shimoda A, Wong D. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proceedings of the National Academy of Sciences of the USA. 93:1996;15394-15399.
83. Caronia S, Taylor K, Pagliaro L. Further evidence for an association between non-insulin dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 30:1999;1059-1063.
84. Allison M ED, Wreghitt T, Palmer C R. Evidence for a link between hepatitis C infection and diabetes mellitus in a cirrhotic population. Journal of Hepatology. 21:1994;1135-1139.
85. Knobler H, Stagnaro-Green A, Wallenstein S. Higher incidence of diabetes in liver transplant recipients with hepatitis C. Journal of Clinical Gastroenterology. 26:1998;30-33.
86. Kendrick E A, McVicar J P, Kowdley K V. Renal disease in hepatitis C-positive liver transplant recipients. Transplantation. 63:1997;1287-1293.
87. D'Amico G. Renal involvement in hepatitis C infection: cryoglobulinaemic glomerulonephritis. Kidney International. 54:1998;650-671.
88. Cantarell M C, Charco R, Capdevila L. Outcome of hepatitis C virus-associated membranoproliferative glomerulonephritis after liver transplantation. Transplantation. 68:1999;1131-1134.
89. Hiesse C, Samuel D, Bensadoun H. Combined liver and kidney transplantation in patients with chronic nephritis associated with end-stage liver disease. Nephrology Dialysis Transplantation. 10S:1995;129-133.
90. Rahamimov R, Ilan Y, Eid A. Hepatitis C associated cryoglobulinaemia after liver transplantation. Transplantation. 60:1995;1050-1051.